Novo Nordisk A/S: Diabetes Mellitus, Type 2 trials

The registry lists 633 Diabetes Mellitus, Type 2 studies with Novo Nordisk A/S as lead sponsor. 22 are open to participants now and 175 have results posted.

Phase 1 122Phase 2 37Phase 3 184Phase 4 75No phase 215(a study in two phases counts in both)

Studies

Page 6 of 7. Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Safety and Efficacy Study of NovoRapid™ in Patients With Coexisting Diabetes and Kidney DiseaseWithdrawnNCT00849316
• Safety of NovoMix® 30 or Levemir® for Treatment of Type 2 Diabetics in MacedoniaCompletedNCT00842894
• An Observational Study in Type 2 Diabetic Patients on Oral Antidiabetic Drugs and Basal Insulin in Near East CountriesCompletedNCT00842192
• A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psychosocial Aspects of Diabetic Subjects in BangladeshCompletedNCT00839878
• A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psychosocial Aspects of Diabetic Subjects in SingaporeCompletedNCT00836030
• Observational Study on Safety and Efficacy of Biphasic Insulin Aspart in Type 2 Diabetes PatientsCompletedNCT00834262
• Effect of Renal Impairment on the Pharmacokinetics of NN9535CompletedNCT00833716Phase 1
• Observational Study to Evaluate the Safety of Levemir® in Type 2 DiabetesCompletedNCT00825643
• Pharmacokinetics and Pharmacodynamics of Biphasic Insulin Aspart 30 and Biphasic Human Insulin 30 in Type 2 DiabetesCompletedNCT00825253Phase 1
• Comparison of Pharmacodynamics and Pharmacokinetics of Biphasic Insulin Aspart 30 and Insulin Glargine and Insulin Glulisine Therapy in Subjects With Type 2 DiabetesCompletedNCT00824668Phase 1
• A Clinical Trial Investigating the Comparison of Three Different Concentrations of NN9535 in Healthy Male SubjectsCompletedNCT00813020Phase 1
• Observational Study to Investigate the Efficacy and Safety of Human Insulin or Insulin Analogue Treatments in Type 2 Diabetes SubjectsCompletedNCT00806936
• Observational Study in Type 2 Diabetics Treated by an Intensive Insulin Treatment of Levemir®CompletedNCT00806897
• Observational Study of NovoPen® 4 on Treatment Satisfaction of Insulin Therapy in Type 1 or Type 2 Subjects With Diabetes MellitusCompletedNCT00806858
• A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psychosocial Aspects of Diabetic Subjects in ThailandCompletedNCT00805922
• Comparison of Efficacy and Safety of Repaglinide Combined With Insulin NPH Versus Biphasic Human Insulin 30 Alone in Inadequately Controlled Subjects With Type 2 DiabetesTerminatedNCT00799448Phase 4
• Observational Study to Observe the Efficacy of Levemir® (Insulin Detemir) in Patients With Type 2 Diabetes.CompletedNCT00793273
• Efficacy of Biphasic Insulin Aspart 30 in Type 2 Diabetics Failing on OADsCompletedNCT00791895Phase 4
• An Observational Study to Compare the Safety and Effectiveness of NovoMix® 30 and Levemir™ for the Treatment of DiabetesCompletedNCT00789711
• A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psychosocial Aspects of Diabetic Subjects in IndonesiaCompletedNCT00788853
• Observational Study Evaluating the Safety of NovoMix® in Type 2 Diabetes Patients Previously Treated With a Human Premix InsulinCompletedNCT00775736
• Observational Study to Evaluate the Effectiveness and Safety of Levemir®, NovoMix® 30 and NovoRapid® in Insulin naïve Subjects With Type 2 DiabetesCompletedNCT00771680
• Observational Study of NovoMix® 50 for Treatment of Type 2 Diabetics for 12 MonthsCompletedNCT00755833
• Switch From Metformin Monotherapy to a Bitherapy With Metformin and RepaglinideCompletedNCT00745433
• Observational Study on Safety of Self-titration of Once Daily Levemir®CompletedNCT00740519
• An Observational Study on Efficacy and Safety in Subjects Using Levemir® for the Treatment of Insulin Dependent Type 1 or Type 2 DiabetesCompletedNCT00738153
• Observational Study on Efficacy and Safety in Patients Using NovoMix® 30 for the Treatment of DiabetesCompletedNCT00737776
• Observational Study to Observe the Safety of Levemir® Treatment in Patients With Type 2 DiabetesCompletedNCT00735501
• Observational Study to Observe the Safety of NovoMix® 30 Treatment in Patients With Type 2 DiabetesCompletedNCT00729898
• Observational Study to Evaluate Safety and Efficacy of Insulin Therapy in Type 2 Diabetes Mellitus Subjects Failing on Oral Anti-diabetic AgentsCompletedNCT00715780
• Observational Study to Evaluate Safety, Efficacy and Convenience of Using NovoMix® 30 FlexPen® in Type 2 DiabetesCompletedNCT00715663
• Observational Study of Patients Using Levemir® or Insulatard® as Start Insulin for Treatment of DiabetesCompletedNCT00715351
• Observational Study Describing Conditions for Intensification of Insulin Therapy in Type 2 DiabetesCompletedNCT00712478
• Observational Study of the Switch of Metformin Alone to Metformin Combined With Repaglinide in Type 2 DiabetesCompletedNCT00709917
• Observational Study to Evaluate the Safety of NovoMix® 30 FlexPen®CompletedNCT00709683
• Observational Safety Study in Subjects Using Levemir® (Insulin Detemir) for the Treatment of Type 2 Diabetes MellitusCompletedNCT00709475
• Observational Study to Evaluate the Safety of Levemir® in DiabetesCompletedNCT00706017
• Observational Study to Observe the Safety of Levemir® Treatment in Children and Adolescents With Type 1 DiabetesCompletedNCT00704574
• Observational Study to Evaluate the Safety and Efficacy of NovoMix® 70 in Type 2 DiabetesCompletedNCT00704223
• Observational Study to Evaluate the Safety While Using Levemir®CompletedNCT00701155
• Observational Study Describing Conditions for Administering Slow-acting Insulin Analogue With Oral Antidiabetic Agents in Type 2 Diabetes on Blood Glucose ControlCompletedNCT00700960
• Observational Study to Evaluate the Safety and Efficacy of Levemir® in Type 2 DiabetesCompletedNCT00700830
• Observational Study to Evaluate Safety of Levemir® in Type 1 and Type 2 DiabetesCompletedNCT00700765
• An Observational Study to Assess Safety and Effectiveness of Intravenous NovoRapid® in Hospitalised SubjectsCompletedNCT00700648
• Observational Study to Evaluate the Efficacy and Safety of NovoMix® 30 in Type 1 and 2 DiabetesCompletedNCT00699179
• Safety and Efficacy of Biphasic Human Insulin Compared to EX1000 in Type 2 DiabetesCompletedNCT00698802Phase 2
• An Observational Study of Efficacy and Safety of Modern Insulin in Diabetes Patients Switched From Anti-diabetic TreatmentCompletedNCT00698269
• Observational Study of Patients Using NovoRapid® or Soluble Human Insulin for Treatment of Type 2 DiabetesCompletedNCT00698126
• Observational Study on the Weight Effect of Insulin Detemir (Levemir®) in Type 2 DiabeticsCompletedNCT00697450
• An Observational Study of Type 2 Diabetes in Patients Starting on NovoMix® 30 TreatmentCompletedNCT00696995
• Observational Study to Assess the Quality of Life and Clinical Outcomes in Subjects Using NovoMix® 30 for the Treatment of DiabetesCompletedNCT00696163
• Observational Study of Glycaemic Control in Patients Uncontrolled on Oral Antidiabetic Agents and Starting With 1 (Once) Daily Levemir® (Insulin Detemir) as the Treatment of Type 2 Diabetes MellitusCompletedNCT00687284
• Observational Study of Safety and Efficacy of Levemir® in Type 2 DiabetesCompletedNCT00687063
• Comparison of the Pharmacodynamics and Pharmacokinetics of Insulin Aspart and Human Insulin in Elderly People With Type 2 DiabetesCompletedNCT00676819Phase 4
• Observational Study on Blood Glucose Control in Patients With Diabetes Using Modern InsulinCompletedNCT00676741
• Observational Study of Type 1 and Type 2 Diabetes Patients Having Switched From Human Premixes to NovoMix®30CompletedNCT00675493
• Observational Study to Assess the Efficacy and Safety of NovoRapid™ Flexpen™CompletedNCT00675220
• Observational Study of Patients Using NovoMix® 30 or Levemir® for Treatment of Type 1 or Type 2 DiabetesCompletedNCT00671008
• Observational Study on Blood Glucose Control in Patients With Diabetes Using Modern InsulinCompletedNCT00670722
• Observational Study of Patients With Diabetes Using Levemir® FlexPen®CompletedNCT00670683
• Observational Study on Treatment Satisfaction of Levemir® Versus Protaphane® During "Real-life" Usage in GermanyCompletedNCT00665808
• Observational Study of Patients Using NovoMix® 30 or Levemir® for Treatment of Type 1 or Type 2 DiabetesCompletedNCT00665093
• Safety and Efficacy of Insulin NPH Compared to a New Insulin Formulation in Subjects With Type 2 DiabetesCompletedNCT00660374Phase 2
• Observational Study of Safety and Effectiveness of NovoMix® 30 for the Treatment of DiabetesCompletedNCT00659282
• Observational Study of Type 2 Diabetes Patients Failing on Oral Anti-diabetic Agents Initiated on Levemir® or Insulatard®CompletedNCT00658099
• Observational Study in Type 2 Diabetes Treated by an Intensive Insulin Treatment (ICT) Containing Once Daily Levemir® (Insulin Detemir)CompletedNCT00657930
• Glycaemic Control and Quality of Care in Type 2 Diabetes on NovoMix® 30 Previously Treated With Mixtard® InsulinsCompletedNCT00657319
• Observational Study of Safety and Tolerability of Levemir™ FlexPen™ (Insulin Detemir) in the Treatment of Type 1 and Type 2 Diabetes MellitusCompletedNCT00655200
• Evaluation of Levemir® for the Treatment of Type 1 and 2 DiabetesCompletedNCT00655044
• Efficacy and Safety of Biphasic Insulin Aspart 30 With Metformin in Type 2 DiabetesCompletedNCT00624364Phase 4
• Efficacy and Safety of Biphasic Insulin Aspart 30 in Combination With Metformin in Type 2 DiabetesCompletedNCT00619697Phase 4
• Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 1 or 2 DiabetesCompletedNCT00617565Phase 3
• Comparison of Pharmacodynamics and Pharmacokinetics of Biphasic Insulin Aspart 50 to Biphasic Insulin Aspart 70 in Type 2 DiabetesCompletedNCT00612599Phase 3
• Efficacy and Safety of Biphasic Insulin Aspart 30 in Subjects With Type 2 DiabetesCompletedNCT00605111Phase 4
• Efficacy and Safety of Insulin Detemir in Combination With Insulin Aspart and Biphasic Insulin Aspart 30 in Type 2 DiabetesCompletedNCT00605020Phase 3
• Safety and Efficacy of Insulin Detemir in Combination With OAD in Type 2 DiabetesCompletedNCT00604396Phase 3
• Efficacy and Safety of Insulin Detemir in Type 2 Diabetes Inadequately Controlled on OHA Therapy AloneCompletedNCT00604253Phase 3
• Basal Bolus of Insulin Aspart Including Insulin NPH and Biphasic Insulin Aspart in Type 2 DiabetesCompletedNCT00600626Phase 3
• Efficacy and Safety of Biphasic Insulin Aspart 30 FlexPen® in Insulin Naive Subjects With Type 2 DiabetesCompletedNCT00600366Phase 4
• Biphasic Insulin Aspart 30 in Type 2 Diabetes Failing OAD TherapyCompletedNCT00598793Phase 3
• Efficacy and Safety of Insulin Aspart in Subjects With Type 1 or Type 2 DiabetesCompletedNCT00593255Phase 4
• Efficacy and Safety of Metformin Plus Biphasic Insulin Aspart 30 in Type 2 DiabetesCompletedNCT00592969Phase 4
• Safety and Efficacy of Insulin Detemir in Combination With OADs in Type 2 DiabetesCompletedNCT00592527Phase 3
• Initiation of Insulin Aspart in Type 2 DiabetesCompletedNCT00572806Phase 4
• Comparison of Glycemic Control Achieved With 2 Different NeedlesCompletedNCT00572052Phase 4
• Comparison of Two Pen Systems in Patients With Diabetes Treated With InsulinCompletedNCT00569998Phase 3
• Evaluating the Use of Two Different Needles in Subjects With DiabetesCompletedNCT00569426Phase 4
• Efficacy and Safety of Repaglinide and Metformin Combined in Type 2 DiabetesCompletedNCT00568984Phase 4
• Efficacy and Safety of Repaglinide, Glurenorm® and Glucobay® in Chinese Subjects With Type 2 DiabetesCompletedNCT00568074Phase 4
• Comparison of Biphasic Insulin Aspart Produced by the NN2000 Process to Current Process to in Type 2 DiabetesCompletedNCT00564668Phase 3
• Safety of Inhaled Preprandial Human Insulin in Subjects With Diabetes and AsthmaTerminatedNCT00523042Phase 3
• The Effect of Insulin Detemir on Blood Glucose Control in Taiwanese Patients With Type 2 Diabetes Failing on OADCompletedNCT00521690Phase 4
• Comparison of Insulin Detemir Versus Insulin NPH on Weight Change in Overweight and Obese With Type 2 DiabetesCompletedNCT00504673Phase 3
• Self-control Trial to Evaluate the Remission Rate in Newly Diagnosed Type 2 Diabetes Patients After Treatment With Insulin AspartCompletedNCT00494988Phase 4
• Efficacy and Safety of Repaglinide and Metformin Combination Therapy in Type 2 Diabetes Failing on Oral Anti-diabetic DrugsCompletedNCT00491725Phase 4
• Safety and Effect of Biphasic Insulin Aspart 50 in Patients With Type 2 Diabetes Mellitus.CompletedNCT00476437Phase 3
• Safety of Inhaled Human Insulin in Subjects With Diabetes Mellitus and Chronic Obstructive Pulmonary Disease (COPD)TerminatedNCT00472953Phase 3
• Efficacy and Safety of Inhaled Insulin Compared to Metformin and Glimepiride in Type 2 DiabetesTerminatedNCT00469586Phase 3
• Effect of Inhaled Pre-prandial Human Insulin on Blood Glucose Control in Type 2 DiabetesTerminatedNCT00427154Phase 3
• Effect of Inhaled Insulin (AERx® iDMS) on Blood Glucose Control in Type 2 DiabetesTerminatedNCT00411892Phase 3